• 1. An amide probe as a selective Al3+ and Fe3+ sensor inside the HeLa and a549 cell lines: Pictet–Spengler reaction for the rapid detection of tryptophan amino acid?
  Bidyut Kumar Kundu,Rinky Singh,Ritudhwaj Tiwari,Debasis Nayak New J. Chem., 2019,43, 4867-4877
• 2. An Appraisal of pH triggered Bacitracin drug release, through composite hydrogel systems
  RabailGul,MariamMir,MurtazaNAli
• 3. An atlas of endohedral Sc2S cluster fullerenes?
  Li-Hua Gan,Rui Wu,Jian-Lei Tian,Patrick W. Fowler Phys. Chem. Chem. Phys., 2017,19, 419-425
• 4. An amorphous carbon nitride/NiO/CoN-based composite: a highly efficient nonprecious electrode for supercapacitors and the oxygen evolution reaction?
  Huifang Yang,Haoran Guo,Peidong Fan,Xinpan Li,Wenlu Ren,Rui Song Nanoscale, 2020,12, 7024-7034
• 5. An intensified π-hole in beryllium-doped boron nitride meshes: its determinant role in CO2 conversion into hydrocarbon fuels?
  Luis Miguel Azofra,Douglas R. MacFarlane,Chenghua Sun Chem. Commun., 2016,52, 3548-3551

Introduction to 5-Chloroquinolin-6-ol (CAS No: 64165-35-1)

5-Chloroquinolin-6-ol, identified by its Chemical Abstracts Service (CAS) number 64165-35-1, is a significant compound in the field of pharmaceutical chemistry and medicinal research. This heterocyclic aromatic compound belongs to the quinoline family, which has long been recognized for its diverse biological activities and therapeutic potential. The presence of a chlorine substituent at the 5-position and a hydroxyl group at the 6-position introduces unique electronic and steric properties, making it a valuable scaffold for drug discovery and development.

The structure of 5-Chloroquinolin-6-ol features a benzene ring fused to a pyridine ring, with the chlorine atom and hydroxyl group positioned strategically to influence its reactivity and interactions with biological targets. This arrangement allows for selective modifications, enabling chemists to explore its pharmacophoric properties and develop derivatives with enhanced efficacy and reduced side effects. The compound’s versatility has garnered interest in both academic research and industrial applications, particularly in the synthesis of novel antimicrobial, antiviral, and anticancer agents.

In recent years, 5-Chloroquinolin-6-ol has been the subject of extensive studies due to its potential in addressing emerging infectious diseases and chronic conditions. The quinoline scaffold is well-documented for its ability to interfere with essential bacterial processes, making it a cornerstone in the development of antibiotics. Furthermore, modifications to this core structure have led to the discovery of drugs that exhibit activity against resistant strains of pathogens, highlighting the importance of 5-Chloroquinolin-6-ol as a starting material.

One of the most compelling aspects of 5-Chloroquinolin-6-ol is its role in developing next-generation antimalarial agents. Malaria remains a significant global health challenge, and the emergence of drug-resistant Plasmodium species has underscored the need for innovative therapeutic strategies. Researchers have leveraged the scaffold’s structural features to design compounds that target multiple stages of the parasite’s life cycle. For instance, derivatives of 5-Chloroquinolin-6-ol have shown promise in preclinical studies by inhibiting key enzymes involved in hemoglobin digestion within red blood cells, thereby disrupting parasite survival.

Additionally, 5-Chloroquinolin-6-ol has been explored for its potential in oncology research. Quinoline derivatives are known to exhibit inhibitory effects on various cancer pathways, including those involving kinases and transcription factors. Studies have demonstrated that modifications to the quinoline core can enhance binding affinity to target proteins, leading to more potent antitumor activity. The chlorine substituent at the 5-position plays a crucial role in modulating these interactions, making it a key focus in structure-activity relationship (SAR) studies aimed at optimizing drug candidates.

The synthesis of 5-Chloroquinolin-6-ol involves multi-step organic reactions that highlight its synthetic utility. Traditional methods include chlorination of quinoline derivatives followed by hydroxylation at the desired position. Advances in catalytic processes have enabled more efficient and environmentally friendly routes, reducing waste generation and improving yield. These innovations align with global efforts to promote sustainable chemistry practices in pharmaceutical manufacturing.

In conclusion, 5-Chloroquinolin-6-ol (CAS No: 64165-35-1) represents a cornerstone compound in medicinal chemistry with far-reaching implications for human health. Its unique structural features and biological activities make it an indispensable tool for researchers seeking to develop novel therapeutics against infectious diseases and cancer. As scientific understanding evolves, continued exploration of this compound will undoubtedly yield groundbreaking discoveries that improve patient outcomes worldwide.

• 773-76-2(Chloroxine)
• 858279-05-7(4,7-Dichloro-6-methoxyquinoline)
• 876-86-8(7-Chloro-8-quinolinol)
• 181950-57-2(4-chloroquinolin-7-ol)
• 14039-98-6([Cu(5,7-Cl-8-HQ)2])
• 32435-60-2(4-chloroquinolin-3-ol)
• 918488-41-2(5-chloro-6-Isoquinolinol)
• 172078-40-9(6-chloro-1H-indol-5-ol)
• 148018-29-5(4-chloroquinolin-6-ol)
• 1236162-17-6(6-chloro-5-Quinolinol)